Projects funded by the NCN
Research of a new small-molecule 1,2,4-triazine derivative (MM-129) - assessment of anti-neoplastic activity and safety of use in an experimental model of colorectal carcinoma.
2018/31/B/NZ7/00875
Keywords:
1,2,4-triazines derivatives colon cancer Zebrafish mouse xenograft model
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Uniwersytet Medyczny w Białymstoku, Wydział Farmaceutyczny z Oddziałem Medycyny Laboratoryjnej
woj. podlaskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 10
Call: OPUS 16 - announced on 2018-09-14
Amount awarded: 1 434 320 PLN
Project start date (Y-m-d): 2019-06-28
Project end date (Y-m-d): 2022-12-27
Project duration:: 42 months (the same as in the proposal)
Project status: Project settled
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.